News

Under our Group corporate philosophy, the “Sysmex Way”, Sysmex has formulated a long-term corporate strategy with fiscal 2033 as the final year. It involves responding to increasingly diverse and complex healthcare needs and promoting business activities to address various social issues, aiming to provide anshin (a sense of security, trust, and confidence), a core principle of our corporate philosophy, to all stakeholders. Also, in order to achieve the goal of “Together for a better healthcare journey”¹ in its long-term vision, Sysmex recognizes that it will be essential to accelerate the creation of innovation in existing business domains as well as to accelerate R&D in the new domains of pre-symptomatic and preventive medicine and treatment using open innovation.

 

Against this background, based on the concept of “Connecting people and spaces,” Sysmex has established HCST at a location with easy access to central Tokyo. The objective of this new R&D hub is to accelerate creative collaboration with various external partners (academia, medical institutions, other companies) involved in healthcare.

 

HCST is equipped with an environment that allows for the safe handling of medical big data and clinical data, as well as wet laboratory² functionality. This enables proper information management and operations, facilitating highly confidential data analysis and providing the ability to validate various measurement technologies, including those unique to Sysmex.

 

In addition, the establishment of a communication area and a collaboration laboratory within the facility will strengthen partnership and accelerate collaboration with external parties in various areas. Seamless linking of data and information gained from collaborative activities through digital communication between HCST and Technopark, Sysmex’s core R&D facility in Kobe, will realize real-time, high-flexibility R&D that transcends the confines of individual facilities.

 

To achieve a better healthcare journey for all people, Sysmex is working on creating high-value testing and diagnostic technologies that support optimal medical care through creative collaboration with various external partners.